Yamaha Motor Co., Ltd. Have confirmed that the YZR-M1 machines will be powered by the V4 engine from the 2026 season onwards. This decision aligns with Yamaha's intentions to transition, underlining ...
FOSTER CITY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (Terns or the Company) (Nasdaq: TERN), a clinical stage oncology company, today announced that data from the ongoing ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Corbus ...
CRB-701 targets Nectin-4, delivering chemotherapy directly to cancer cells, minimizing damage to healthy tissue. The FDA's fast track designation aims to expedite CRB-701's development for HNSCC and ...
OnlyFans has paid its owner Leonid Radvinsky $701 million in dividends, including a record amount for 2024, ahead of a potential sale of the adult-content social network. The payout was disclosed in ...
Ukrainian-American entrepreneur Leonid Radvinsky extracted a record $701 million dividend from OnlyFans ahead of active sale negotiations that could value the content subscription platform at $7 ...
FOSTER CITY, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small ...
Through the looking glass: In early 1995, IBM sent shockwaves through the laptop industry with the introduction of the ThinkPad 701, a device that appeared to be just another unassuming black ...
High-horsepower speed machines and massive cross-country touring bikes are where lots of riders gravitate. However, they can be expensive, tough to maintain, and not ideal for new riders. For newbies, ...
Yamaha is the default brand that people think of when someone says "motorcycle" — and it's been that way for decades. Today, Yamaha has an extremely wide roster of models to choose from on sale in the ...
Just two months after Inozyme Pharma Inc. cut its workforce by 25% and prioritized activities to focus on a BLA filing for INZ-701 for ENPP1 deficiency, interim phase III data from its Energy 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results